“Women who want to be screened for cervical cancer have just received a new option — and a new quandary”

A recent New York Times editorial http://www.nytimes.com * noted. “The venerable Pap smear, which has been the only screening tool to look for cancer in asymptomatic women for many decades, now has a rival, a genetic test that looks for the viruses implicated in causing cervical cancer.”
“Adding a new option seems a positive development. Yet some critics have opposed using the new test as a primary screening tool lest it displace the Pap test, which has been credited with cutting the incidence and death rate from cervical cancer sharply in recent decades.”
“Which test is better? The F.D.A. made no comparative judgment. It simply said that a well-designed study by Roche provided reasonable assurance that the test was safe and effective when used as a primary screening tool.”
“The new test is not expected to replace Pap smears in the United States any time soon. Professional societies will first need to develop guidelines on when and how doctors should use it. But it is welcome news that an effective new screening test for cervical cancer is available should women prefer that option.”
Something to be discussed with your primary care physician and obstetrician/ gynecologist!
* to read the full NYT editorial “Are Pap Smears on the Way Out?”, highlight and click on open hyperlink
http://www.nytimes.com/2014/05/05/opinion/are-pap-smears-on-the-way-out.html?_r=0
Note: This blog shares general information about understanding and navigating the health care system. For specific medical advice about your own problems, issues and options talk to your personal physician.

CategoriesUncategorized

© 2000, Newspaper Media Group